U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H21ClN2S
Molecular Weight 344.901
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOROTEPINE

SMILES

CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(Cl)C=C4

InChI

InChIKey=XRYLGRGAWQSVQW-UHFFFAOYSA-N
InChI=1S/C19H21ClN2S/c1-21-8-10-22(11-9-21)17-12-14-4-2-3-5-18(14)23-19-7-6-15(20)13-16(17)19/h2-7,13,17H,8-12H2,1H3

HIDE SMILES / InChI

Molecular Formula C19H21ClN2S
Molecular Weight 344.901
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Clorotepine (aka octoclothepin or octoclothepine) is an antipsychotic from the tricyclic group derived from perathiepin. It was originally developed in 1965 and marketed in the Czech Republic by Spofa in or around 1971 for the treatment of schizophrenic psychosis. Clorotepine has a high affinity for the dopamine (D1, D2, D3, D4), receptors the serotonin 5-HT (2A, 2B, 2C, 6, 7) receptors, the alpha-adrenergic receptors (1A, 1B, 1D), and the histamine H1 receptors. In most instances, it acts as an antagonist (or inverse agonist). Clorotepine will also block the reuptake of norepinephrine by inhibiting the norepinephrine transporter.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P28223
Gene ID: 3356.0
Gene Symbol: HTR2A
Target Organism: Homo sapiens (Human)
0.57 nM [IC50]
Target ID: P35348|||B0ZBD9|||Q6RUJ8
Gene ID: 148.0
Gene Symbol: ADRA1A
Target Organism: Homo sapiens (Human)
0.18 nM [IC50]
Target ID: P21728
Gene ID: 1812.0
Gene Symbol: DRD1
Target Organism: Homo sapiens (Human)
2.2 nM [IC50]
Target ID: P14416
Gene ID: 1813.0
Gene Symbol: DRD2
Target Organism: Homo sapiens (Human)
2.4 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Clotepin

Approved Use

Unknown
Primary
Clotepin

Approved Use

Unknown
Primary
Clotepin

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Clinical experience with octoclothepine in chronic mental patients.
1972
Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
1978 Dec
Further clinical experiences with optical isomers of the L and D clorothepin.
1979
On acute effects of some drugs on the higher nervous activity in man. Clorotepin (2 mg), its (+)-enantiomer (2 mg) and (-)-enantiomer (2 mg).
1980
On acute effects of some drugs on the higher nervous activity in man (the acoustic analyser). Clorotepin (0.5 mg and 1.0 mg), pemoline (100 mg). Part LI.
1985
Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists.
1991 Jul
Molecular field analysis of clozapine analogs in the development of a pharmacophore model of antipsychotic drug action.
2001
Patents

Sample Use Guides

Clorotepin is provided in doses up to 2 mg.
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:30:50 UTC 2023
Edited
by admin
on Fri Dec 15 16:30:50 UTC 2023
Record UNII
E65W20MU7A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOROTEPINE
INN   WHO-DD  
INN  
Official Name English
PIPERAZINE, 1-(8-CHLORO-10,11-DIHYDRODIBENZO(B,F)THIEPIN-10-YL)-4-METHYL-
Systematic Name English
Clorotepine [WHO-DD]
Common Name English
OCTOCLOTHEPINE
Common Name English
(±)-OCTOCLOTHEPIN
Common Name English
CLOTHEPIN
Common Name English
1-(8-CHLORO-10,11-DIHYDRODIBENZO(B,F)THIEPIN-10-YL)-4-METHYLPIPERAZINE
Systematic Name English
clorotepine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66883
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
Code System Code Type Description
PUBCHEM
1238
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
FDA UNII
E65W20MU7A
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
WIKIPEDIA
Clorotepine
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
INN
3423
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
SMS_ID
100000084010
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
EPA CompTox
DTXSID7048451
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
CAS
13448-22-1
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL64249
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
MESH
C100288
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
NCI_THESAURUS
C77572
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
DRUG CENTRAL
3912
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
EVMPD
SUB06765MIG
Created by admin on Fri Dec 15 16:30:50 UTC 2023 , Edited by admin on Fri Dec 15 16:30:50 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY